Current therapeutic options for colorectal liver metastases

Indian Journal of Gastroenterology

Volumn 26, Issue 1, 2007, Pages 26-29

  Vadeyar, H J ^a  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; LIQUID NITROGEN; OXALIPLATIN; VASCULOTROPIN;

ARTIFICIAL EMBOLISM; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; GEOGRAPHIC DISTRIBUTION; HUMAN; LIVER METASTASIS; LIVER RESECTION; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PORTAL VEIN; POSITRON EMISSION TOMOGRAPHY; RADIOFREQUENCY ABLATION; REVIEW;

CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DIAGNOSTIC IMAGING; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; PATIENT SELECTION;

EID: 34248150811     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Mohandas KM, Desai DC. Epidemiology of digestive tract cancers in India. V. Large and small bowel. Indian J Gastroenterol 1999;18:118-21.
2. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J, et al. Guidelines for resection of colorectal liver metastases. Gut 2006;55(Suppl III):1-8.
3. Kemeny N, Fata F. Arterial, portal or systemic chemotherapy for patients with hepatic metastases of colorectal carcinoma. J Hepatobil Pancreat Surg 1999;6:39-49.
4. Seifert JK, Junginger T, Morris DL. A collective review of the world literature on hepatic cryotherapy. J R Coll Surg Edin 1998;43:141-4.
5. Borner MM. Neoadjuvant chemotherapy for unresectable metastases of colorectal cancer - too good to be true? Ann Oncol 1999;10:623-6.
6. Fong Y, Cohen AM, Fortner JG, Enker WE, Turnbull AD, Coit DG, et al. Liver resection for colrectal metastases. J Clin Oncol 1997;15:938-46.
7. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994;343:1405-10.
8. Choti MA, Bulkley GB. Management of hepatic metastases. Liver Transpl Surg 1999;5:65-80.
9. Fong Y, Fortner JG, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-18.
10. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
11. Cody B, Stone MD. The role of surgical resection of liver metastases in colorectal carcinoma. Semin Oncol 1991;18:399-406.
12. Geogeghan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg 1999;86:158-69.
13. Sahani DV, Kalva SP. Imaging the liver. Oncologist 2004;9:385-97.
14. Ward BA, Miller DL, Frank JA, Dwyer AJ, Simmons JT, Chang R, et al. Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings. Surgery 1989;105:180-7.
15. Fong Y, Saldinger PF, Akhurst T, Macapinlac H, Yeung H, Finn RD, et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of colorectal liver metastases. Am J Surg 1999;178:2827.
16. Israel O, Mor M, Gaitini D, Keidar Z, Guralnik L, Engel A, et al. Combined structural and functional evaluation of cancer patients with a hybrid camera based PET/CT system 18FDG. J Nucl Med 2002;43:1129-36.
17. Elias D, Cavalcanti A, Sabourin JC, Lassau N, Pignon JP, Ducreux M, et al. Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol 1998;24:174-9.
18. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997;132:505-11.
19. Kokudo N, Sato T, Seki M, Ohta H, Azekura K, Ueno M, et al. Hepatic lymph node involvement in resected cases of liver metastases from colorectal cancer. Dis Colon Rectum 1999;42:1285-91.
20. Hughes K, Scheele J, Sugarbaker PH. Surgery for colorectal cancer metastases to the liver: optimizing the results of treatment. Surg Clin North Am 1989;69:339-43.
21. Smith JW, Fortner JG, Burt M, et al. Resection of hepatic and pulmonary metastases from colorectal cancer. Surg Oncol 1992;1:399-404.
22. Murata S, Moriya Y, Akasu T, Fujita S, Sugihara K. Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 1998;83:108693.
23. Poston GJ. Surgical strategies for colorectal liver metastases. Surg Oncol 2004;13:125-36.
24. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long term results. Ann Surg 2000;231:487-99.
25. Elias D, Liberale G, Vernerey D, Pocard M, Ducreux M, Boige V, et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 2005;12:900-9.
26. Vauthey JN. Patients with hepatic colorectal metastases. Proceedings of the AHPBA Consensus Conference. San Francisco, CA, USA, 2006.
27. Jones OM, Rees M, John TG, Bygrave S, Plant G. Biopsy of resectable colorectal metastases causes tumour dissemination and adversely affects survival after liver resection. Br J Surg 2005;92:1165-8.
28. Jones OM, Rees M, John TG, Bygrave S, Plant G. Biopsy of potentially operable hepatic colorectal metastases is not useless but dangerous. Br Med J 2004;329:1045-6.
29. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-20.
30. Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, et al. Long term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999;10:663-9.
31. Giacchetti S, Perpoint B, Zidani R, Le Bail N, Faggiuolo R, Focan C, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first line treatment of metastatic colorectal cancer. J Clin Oncol 2000;18:136-47.
32. Pozzo C, Basso M, Cassano A, Quirino M, Schinzari G, Trigila N, et al. Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 2004;15:933-9.
33. O'Reilly DA, Poston GJ. Colorectal liver metastases: current and future perspectives. Future Oncol 2006;2:525-31.
34. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al. Preoperative portal vein embolisation to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107:521-7.
35. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986;10:803-8.
36. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 1995;21:434-9.
37. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolisation: rationale, technique and future prospects. Br J Surg 2001;88:165-75.
38. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 2000;232:777-85.
39. Sheen A, Poston GJ, Sherlock DJ. Cryotherapeutic ablation of liver tumours. Br J Surg 2002;89:1396-401.
40. Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998;228:201-8.
41. Weaver ML, Ashton JG, Zemel R. Treatment of colorectal liver metastases by cryotherapy. Semin Surg Oncol 1998;14:163-70.
42. Morris DL, Horton MD, Dilley AV, Warlters A, Clingan PR. Treatment of hepatic metastases by cryotherapy and regional cytotoxic perfusion. Gut 1993;34:1156-7.
43. Siperstein A, Garland A, Engle K, Rogers S, Berber E, Foroutani A, et al. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors. Ann Surg Oncol 2000;7:106-13.
44. Solbiati L, Ierace T, Goldberg SN, Sironi S, Livraghi T, Fiocca R, et al. Percutaneous ultrasound guided radiofrequency tissue ablation of liver metastases: treatment and follow up in 16 patients. Radiology 1997;202:195-203.
45. Bilchik AJ, Wood TF, Allegra D, Tsioulias GJ, Chung M, Rose DM, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg 2000;135:657-64.
46. Neeleman N, Andersson R. Repeated liver resection for recurrent cancer. Br J Surg 1996;83:893-901.
47. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-48.